What each drug is, what it does to the cells and receptors of the heart, when the algorithms use it, how much for adults and for children, and what to watch for.
Guidelines: AHA 2020 with the 2023 update and confirmed 2025 changes; PALS 2020 with the 2025 pediatric updates
Reflects the AHA 2020 adult algorithms with the 2023 focused update, updated for the 2025 AHA Guidelines for CPR and ECC where the change could be confirmed; acute coronary syndromes follow the 2025 ACC/AHA guideline and stroke the 2026 AHA/ASA guideline. Pediatric content follows the AHA 2020 PALS algorithms with the 2025 AHA/AAP pediatric updates where confirmed.
Cardiac arrest Pediatric doses
Epinephrine (bolus)
The arrest vasopressor
Class: Catecholamine; alpha- and beta-adrenergic agonist
How it works
In cardiac arrest the alpha-1 effect matters most: it squeezes peripheral arteries, raising aortic diastolic pressure and with it the coronary perfusion pressure that compressions generate. Beta-1 stimulation raises rate and contractility, which helps after ROSC but increases the heart's oxygen demand.
A picture of the mechanism appears here with JavaScript on.
When it is used
Every pulseless rhythm: VF, pulseless VT, asystole and PEA.
Non-shockable rhythms: give it as soon as possible.
Shockable rhythms: give it after the initial shocks have failed (in the algorithm, after the second shock).
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Cardiac arrest
1 mgIV/IO
every 3–5 minutes; no maximum
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Pediatric Pediatric cardiac arrest, or bradycardia with poor perfusion despite oxygenation and ventilation
0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL)IV/IO
every 3–5 minutes; 1 mg per dose
AHA 2020 PALS algorithms; 2025 AHA/AAP PALS algorithm
Do not use, or take care
No absolute contraindication in cardiac arrest.
After ROSC it can provoke tachycardia, ectopy and recurrent VF.
Higher (escalating) doses are not recommended: they did not improve survival.
Flush each dose; IV is the first-choice route, IO if IV cannot be placed.
What it does to the ECG and the heart
In arrest there is no rhythm change to expect from the drug itself. With a pulse: sinus tachycardia, ectopic beats, and in an ischemic heart ST depression or ventricular arrhythmias.
Two clocks run in an arrest: the 2-minute CPR cycle and the 3–5-minute epinephrine timer.
Vasopressin offers no advantage over epinephrine and is no longer in the algorithm.
Cardiac arrest Pediatric doses
Amiodarone
Antiarrhythmic for shock-refractory VF/pVT and stable VT
Class: Class III antiarrhythmic (also class I, II and IV effects)
How it works
Blocks potassium channels so the action potential lasts longer and the cell stays refractory longer; a re-entrant wave meets tissue it cannot yet excite and dies out. It also blocks sodium and calcium channels and beta-receptors.
A picture of the mechanism appears here with JavaScript on.
When it is used
VF or pulseless VT that persists after shocks (with lidocaine as the alternative).
Stable regular wide-complex (monomorphic VT) tachycardia, as an infusion.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Cardiac arrest (VF/pVT), first dose
300 mg bolusIV/IO
second dose 150 mg; two doses in the arrest
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Adult Stable wide-QRS tachycardia
150 mg over 10 minutesIV
repeat as needed if VT recurs; then 1 mg/min for the first 6 hours
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Pediatric Pediatric VF/pVT
5 mg/kg bolusIV/IO
up to 3 total doses for refractory VF/pVT; 300 mg per dose
AHA 2020 PALS cardiac arrest algorithm; 2025 algorithm
Pediatric Pediatric wide-complex tachycardia with a pulse
5 mg/kg over 20–60 minutesIV/IO
300 mg
AHA 2020 PALS tachycardia algorithm
Do not use, or take care
With a pulse: cardiogenic shock, marked sinus bradycardia or high-grade AV block without a pacemaker.
Hypotension and bradycardia, especially with rapid infusion.
Prolongs the QT; avoid combining with other QT-prolonging drugs.
Half-life of weeks: effects outlast the resuscitation.
What it does to the ECG and the heart
Slower sinus and AV nodal conduction, a longer QT interval and sometimes a wider QRS.
Arrest dose 300 then 150; stable VT dose 150 over 10 minutes. Same drug, different speeds.
Cardiac arrest Pediatric doses
Lidocaine
The alternative to amiodarone
Class: Class Ib antiarrhythmic (sodium-channel blocker)
How it works
Binds fast sodium channels, mostly in cells that are depolarized and firing fast, such as ischemic tissue. It slows phase 0 there and raises the threshold for re-entry while leaving normal tissue largely alone.
A picture of the mechanism appears here with JavaScript on.
When it is used
VF or pulseless VT persisting after shocks, as an alternative to amiodarone.
May be considered after ROSC from VF/pVT to prevent recurrence.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Cardiac arrest (VF/pVT)
1–1.5 mg/kg first doseIV/IO
0.5–0.75 mg/kg; 3 mg/kg in total
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Pediatric Pediatric VF/pVT
1 mg/kg loading doseIV/IO
—
AHA 2020 PALS cardiac arrest algorithm; 2025 algorithm
Do not use, or take care
High-grade AV block or a slow escape rhythm: it can suppress the escape focus.
Toxicity is neurological first: perioral numbness, confusion, seizures.
Accumulates in heart failure and liver disease.
What it does to the ECG and the heart
Little change at therapeutic doses; toxicity can cause bradycardia and a wider QRS.
Pick amiodarone or lidocaine; there is no evidence that one beats the other for survival to discharge.
Cardiac arrest
Magnesium sulfate
For torsades de pointes
Class: Electrolyte; calcium-channel modulator
How it works
Suppresses the early afterdepolarizations (extra upstrokes during phase 2–3) that trigger torsades when the QT is long, probably by damping L-type calcium current.
A picture of the mechanism appears here with JavaScript on.
When it is used
Polymorphic VT with a long QT (torsades de pointes).
Not for routine use in VF/pVT without torsades.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Torsades de pointes
1–2 gIV/IO, diluted
given over minutes in arrest; more slowly with a pulse
AHA ACLS teaching (2010–2020 guidance); the 2025 text does not change itOwner to check: Confirm the infusion time for a patient with a pulse against local protocol.
Do not use, or take care
Hypermagnesemia; caution in renal failure.
Rapid injection causes flushing, hypotension and bradycardia.
In pregnancy, a magnesium infusion running at arrest should be stopped (toxicity can cause it).
What it does to the ECG and the heart
Fewer early afterdepolarizations: the torsades stops, though the QT may stay long.
A torsades patient without a pulse is defibrillated first; magnesium is the add-on.
Bradycardia Pediatric doses
Atropine
First drug for symptomatic bradycardia
Class: Antimuscarinic (parasympatholytic)
How it works
Blocks M2 muscarinic receptors on the sinus and AV nodes, cutting off the vagal brake. Pacemaker cells drift to threshold faster and the AV node conducts faster. It cannot help tissue the vagus does not reach, such as the His–Purkinje system.
A picture of the mechanism appears here with JavaScript on.
When it is used
Symptomatic sinus bradycardia.
AV block at the level of the node (first degree, Mobitz I).
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Symptomatic bradycardia
1 mg bolusIV
every 3–5 minutes; 3 mg total
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Pediatric Pediatric bradycardia from increased vagal tone or primary AV block
0.02 mg/kgIV/IO
may repeat once; 0.5 mg single dose
AHA 2020 PALS bradycardia algorithmOwner to check: 2020 printed a 0.1 mg minimum dose; confirm against the 2025 PALS text.
Do not use, or take care
Do not let it delay pacing in Mobitz II or third-degree block with a wide escape rhythm.
No longer part of the arrest algorithm (asystole, PEA).
Unlikely to work after heart transplant (no vagal innervation).
Raises oxygen demand: use with care in acute ischemia.
What it does to the ECG and the heart
Faster sinus rate and shorter PR. In infranodal block the ventricular escape rate stays the same; the atrial rate may rise and the block may even worsen.
Micrograms per minute for an infusion, milligrams for the arrest bolus: a thousandfold difference.
Tachycardia Pediatric doses
Adenosine
Momentary AV block
Class: Purine nucleoside; A1-receptor agonist
How it works
Activates A1 receptors in the AV node, which opens potassium channels and cuts cyclic AMP. Nodal cells hyperpolarize and stop conducting for a few seconds. A re-entry circuit that runs through the AV node is broken; other rhythms simply slow briefly and show what is underneath.
A picture of the mechanism appears here with JavaScript on.
Regular narrow tachycardia while preparing to cardiovert, if unstable.
Stable regular monomorphic wide-complex tachycardia, as a diagnostic and possible treatment.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Regular tachycardia
6 mg rapid push, then a saline flushIV
12 mg if needed; two doses in the algorithm
AHA 2020 adult algorithm; unchanged in the 2025 algorithm
Pediatric Pediatric SVT
0.1 mg/kg rapid push (max 6 mg)IV/IO
0.2 mg/kg (max 12 mg)
AHA 2020 PALS tachycardia algorithm
Do not use, or take care
Irregular or polymorphic wide-complex tachycardia (pre-excited AF may accelerate).
Second- or third-degree AV block or sick sinus syndrome without a pacemaker.
Caution in reactive airway disease.
Half-life under 10 seconds: push fast, close to the heart, and flush.
Lower doses for heart transplant, central-line injection, or patients on dipyridamole or carbamazepine; theophylline and caffeine blunt it.
Warn the patient: a brief sense of doom, chest tightness and flushing are expected.
What it does to the ECG and the heart
A few seconds of high-grade AV block or asystole, then either sinus rhythm (re-entry broken) or the same tachycardia with flutter waves or atrial activity revealed.
AHA 2020 tachycardia algorithm; removed from the AHA 2025 algorithmOwner to check: Removal reported in the 2025 interim provider materials; confirm before publishing.
Class: Class IV antiarrhythmics; non-dihydropyridine calcium-channel blockers
How it works
Block L-type calcium channels, which carry the upstroke (phase 0) in sinus and AV nodal cells. Nodal conduction slows, re-entry through the node can stop, and the ventricular response to AF or flutter falls.
A picture of the mechanism appears here with JavaScript on.
When it is used
Stable narrow-complex tachycardia after vagal maneuvers and adenosine.
Rate control in atrial fibrillation or flutter.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Diltiazem
15–20 mg (0.25 mg/kg) over 2 minutesIV
20–25 mg (0.35 mg/kg) after 15 minutes if needed; maintenance 5–15 mg/h
AHA ACLS teaching (2020 provider materials)Owner to check: Not printed on the 2025 algorithm; confirm against local protocol.
Adult Verapamil
2.5–5 mg over 2 minutesIV
5–10 mg every 15–30 minutes; 20 mg
AHA ACLS teaching (2020 provider materials)Owner to check: Not printed on the 2025 algorithm; confirm against local protocol.
Do not use, or take care
Wide-complex tachycardia unless certainly supraventricular: in VT they can cause collapse.
Pre-excited AF (WPW).
Hypotension, heart failure with reduced ejection fraction.
Hypotension; additive with beta-blockers.
What it does to the ECG and the heart
Slower ventricular rate in AF and flutter; a longer PR.
Never for a wide-complex tachycardia you are not sure about.
Blood pressure and post-ROSC Pediatric doses
Isotonic crystalloid (fluid bolus)
Volume for hypovolemia and shock
Class: Isotonic crystalloid (balanced solution or normal saline)
How it works
Restores circulating volume, so more blood returns to the heart, stretches it, and is pumped out (preload, then stroke volume). It cannot help a heart that is already full or failing; too much causes pulmonary edema.
A picture of the mechanism appears here with JavaScript on.
When it is used
Hypovolemia and hemorrhage (with blood products).
Septic shock in children: boluses with reassessment after each.
Post-ROSC hypotension when under-filled.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Adults
Bolus, often 500–1000 mL, reassessing after eachIV/IO
—
AHA ACLS teaching; AHA 2025 post-cardiac arrest care (fluids for hypotension)Owner to check: No single adult bolus volume is printed in the algorithms.
Pediatric Children: shock
10–20 mL/kgIV/IO
reassess after each bolus (perfusion, liver edge, crackles); stop if signs of fluid overload; 5–10 mL/kg if cardiac dysfunction
AHA 2020 PALS (10 or 20 mL/kg aliquots with reassessment); 2025 PALS course materials
Do not use, or take care
Signs of fluid overload: crackles, hepatomegaly, rising work of breathing.
Reassess after every bolus.
Cardiogenic shock needs smaller, slower boluses and early inotropes.
Class: Catecholamine; mainly alpha-1 with some beta-1 agonism
How it works
Constricts arterioles (alpha-1) to raise mean arterial pressure, with a modest increase in contractility (beta-1) and little effect on rate.
A picture of the mechanism appears here with JavaScript on.
When it is used
Hypotension or shock after ROSC that persists after fluids.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Hypotension after ROSC
Titrated infusion to a MAP of at least 65 mm HgIV infusion
—
AHA 2025 post-cardiac arrest care algorithmOwner to check: The 2020 algorithm printed 0.1–0.5 mcg/kg/min; confirm the range the owner wants shown.
Pediatric Pediatric fluid-refractory septic shock
0.05–2 mcg/kg per minute, titratedIV/IO infusion
—
AHA 2020 PALS (epinephrine or norepinephrine as first vasoactive in fluid-refractory septic shock)Owner to check: Range from 2025 course materials; confirm.
Do not use, or take care
Uncorrected hypovolemia.
Extravasation injury; peripheral ischemia at high doses.
What it does to the ECG and the heart
Little direct effect; reflex slowing of the rate is possible.
Remember
Target a MAP of 65 mm Hg or more after ROSC; hypotension worsens brain injury.
Special circumstances
Calcium chloride and gluconate
For hyperkalemia and calcium-channel blocker toxicity
Class: Electrolyte; membrane stabilizer
How it works
In hyperkalemia the resting potential creeps toward threshold. Extra calcium raises the threshold back, restoring the gap between rest and firing, within minutes. It does not lower the potassium.
A picture of the mechanism appears here with JavaScript on.
When it is used
Hyperkalemia with ECG changes or arrest.
Calcium-channel blocker overdose.
Magnesium toxicity (for example in pregnancy).
Not for routine use in cardiac arrest.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Calcium chloride 10%
500–1000 mg (5–10 mL)IV/IO
repeat as needed
AHA ACLS teaching; the 2025 guidelines keep it for specific causes onlyOwner to check: Confirm doses against local protocol.
Adult Calcium gluconate 10%
1.5–3 g (15–30 mL)IV/IO
repeat as needed
AHA ACLS teaching; the 2025 guidelines keep it for specific causes onlyOwner to check: Confirm doses against local protocol.
Do not use, or take care
Digoxin toxicity (relative).
Never in the same line as sodium bicarbonate (precipitates).
Calcium chloride irritates veins: prefer a large or central vein.
What it does to the ECG and the heart
In hyperkalemia: a narrower QRS and a return of the P wave within minutes; peaked T waves may persist.
Remember
Calcium protects the heart; insulin, glucose and bicarbonate move the potassium.
Special circumstances
Sodium bicarbonate
For specific causes, not routine
Class: Alkalinizing agent; sodium load
How it works
Raises pH, which shifts potassium into cells, and loads sodium, which overcomes sodium-channel blockade by tricyclic antidepressants and similar drugs.
A picture of the mechanism appears here with JavaScript on.
When it is used
Hyperkalemia.
Tricyclic or other sodium-channel blocker overdose with a wide QRS.
Pre-existing severe metabolic acidosis.
Not for routine use in cardiac arrest.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Specific causes
1 mEq/kgIV/IO
guided by the cause and the blood gas
AHA ACLS teaching; the 2025 guidelines do not recommend routine useOwner to check: Confirm against local protocol.
Do not use, or take care
Routine use in arrest without one of the causes above.
Produces CO₂, which can worsen intracellular acidosis if ventilation is poor.
Hypernatremia; inactivates catecholamines and precipitates calcium in the same line.
What it does to the ECG and the heart
In sodium-channel blocker toxicity: the QRS narrows and the terminal R in aVR shrinks.
Remember
Treat a cause, not a number.
Special circumstances
Glucagon
For beta-blocker (and calcium-channel blocker) toxicity
Class: Peptide hormone; raises cAMP without the beta receptor
How it works
Glucagon acts on its own receptor on cardiac cells, which raises cAMP just as beta stimulation would. A beta-blocker cannot block it, so it can restore some rate and contractility when the beta receptors are occupied.
A picture of the mechanism appears here with JavaScript on.
When it is used
Symptomatic bradycardia and hypotension from beta-blocker overdose.
Sometimes tried in calcium-channel blocker overdose; calcium and high-dose insulin matter more there.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Beta-blocker toxicity
3–10 mg IV over 3–5 minutes (about 0.05–0.15 mg/kg)IV
then an infusion of 3–5 mg/h if it helps
AHA 2023 focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoningOwner to check: Owner to check the bolus range and infusion rate against the 2023 toxicology update.
Do not use, or take care
Pheochromocytoma (can release catecholamines).
Vomiting is common: protect the airway.
Raises blood glucose; the effect wears off within minutes, so an infusion follows a response.
What it does to the ECG and the heart
A faster sinus or escape rate and better conduction if it works; often a modest effect.
High-dose insulin, calcium and vasopressors are given alongside, not instead.
Bradycardia
Isoproterenol infusion
A pure beta agonist that speeds the heart
Class: Catecholamine; beta-1 and beta-2 agonist
How it works
Stimulates beta-1 receptors (faster rate, faster conduction) and beta-2 receptors (vasodilation). A faster heart rate shortens the QT, which is why it can stop pause-dependent torsades from recurring.
A picture of the mechanism appears here with JavaScript on.
When it is used
Recurrent pause-dependent torsades de pointes with an acquired long QT, as a bridge to overdrive pacing.
Symptomatic bradycardia unresponsive to atropine, where it is available (a second-line chronotrope).
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Infusion
2–10 mcg/min, titrated to the heart rateIV
—
AHA ACLS teaching on bradycardia and torsades de pointesOwner to check: Owner to check: confirm the infusion range and its place in the 2025 bradycardia text.
Do not use, or take care
Congenital long QT syndrome (adrenergic triggers make it worse).
For torsades that keeps coming back after magnesium: raise the rate, with isoproterenol or overdrive pacing.
Special circumstances
Naloxone
Reverses opioid respiratory depression
Class: Opioid receptor antagonist
How it works
Displaces opioids from mu receptors in the brainstem respiratory centre, restoring the drive to breathe. It does nothing for a heart that has stopped: the arrest itself is treated with CPR.
A picture of the mechanism appears here with JavaScript on.
When it is used
Suspected opioid overdose with respiratory depression or respiratory arrest and a pulse.
In opioid-associated cardiac arrest it may be given, but never in place of CPR.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Intranasal
4 mgIN
every 2–3 minutes if no response
AHA 2020 opioid-associated emergency algorithms; 2025 guidelines endorse naloxoneOwner to check: Confirm current product strengths against local protocol.
Adult Intramuscular or intravenous
0.4 mg, titratedIM/IV
every 2–3 minutes; up to 2 mg per dose
AHA 2020 opioid-associated emergency algorithms; 2025 guidelines endorse naloxoneOwner to check: Confirm current product strengths against local protocol.
Do not use, or take care
None in a life-threatening overdose.
Acute withdrawal in dependent patients: agitation, vomiting, pulmonary edema.
Shorter acting than many opioids: watch for re-sedation.
What it does to the ECG and the heart
No direct effect; correcting hypoxia may resolve bradycardia or ectopy.
Remember
Ventilate first. Oxygen and a bag-mask buy time naloxone cannot.
Special circumstances Pediatric doses
Oxygen
A drug with targets
Class: Medical gas
How it works
Raises arterial oxygen content. In arrest, deliver the highest concentration available; once there is circulation, too much is harmful too, so titrate to a target.
A picture of the mechanism appears here with JavaScript on.
When it is used
During CPR: 100%.
After ROSC: titrate to an SpO₂ of 90–98%.
ACS: only if SpO₂ is below 90%.
Bradycardia and tachycardia: if hypoxemic.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult After ROSC
Titrate to SpO₂ 90–98%inhaled
—
AHA 2025 post-cardiac arrest care algorithm
Adult Acute coronary syndromes
Only if SpO₂ < 90%inhaled
—
ACC/AHA 2025 acute coronary syndromes guideline (as taught in ACLS)
Pediatric Children after ROSC
Normoxemia: SpO₂ 94–99%inhaled
—
AHA 2020 PALS post-cardiac arrest careOwner to check: Confirm the 2025 PALS post-arrest SpO₂ target.
Do not use, or take care
None in hypoxemia.
Hyperoxia after ROSC is associated with worse outcomes.
What it does to the ECG and the heart
None directly; hypoxia drives bradycardia and ectopy.
Blocks thromboxane A2 production in platelets for their whole lifespan, so fewer platelets join the thrombus forming on a ruptured plaque.
A picture of the mechanism appears here with JavaScript on.
When it is used
Suspected acute coronary syndrome, as early as possible.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Suspected ACS
162–325 mg, chewed (non-enteric-coated)oral
—
ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS ACS teachingOwner to check: Confirm the dose range the owner wants shown.
Do not use, or take care
True aspirin allergy.
Active gastrointestinal bleeding.
Chewing speeds absorption.
What it does to the ECG and the heart
None.
Remember
Chew it: a swallowed coated tablet takes far longer to work.
ACS and stroke
Nitroglycerin
Preload reduction for ischemic pain
Class: Nitrate vasodilator
How it works
Releases nitric oxide, which relaxes venous smooth muscle more than arterial: venous return (preload) falls, so wall stress and oxygen demand fall. It also dilates coronary arteries.
A picture of the mechanism appears here with JavaScript on.
When it is used
Ongoing ischemic chest discomfort with an adequate blood pressure.
Hypertension or pulmonary edema with ACS.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Ischemic chest discomfort
0.4 mg sublingualSL
every 5 minutes; 3 doses, then consider IV
AHA ACLS ACS teaching; ACC/AHA 2025 ACS guidelineOwner to check: Confirm against local protocol.
Do not use, or take care
Systolic BP below 90 mm Hg (or 30 mm Hg or more below baseline).
Right ventricular infarction (preload dependent).
A phosphodiesterase-5 inhibitor in the last 24 hours (48 hours for tadalafil).
Hypotension, headache.
What it does to the ECG and the heart
None directly; relief of ischemia may resolve ST depression.
Remember
Inferior STEMI? Look at V4R before giving nitrates.
ACS and stroke
Morphine and fentanyl
Analgesia only when nitrates fail
Class: Opioid analgesics
How it works
Mu-receptor agonists: they relieve pain and anxiety and reduce sympathetic drive. Morphine also dilates veins.
A picture of the mechanism appears here with JavaScript on.
When it is used
Chest pain in ACS that persists despite nitrates.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Refractory ischemic pain
Small titrated IV dosesIV
—
ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS ACS teachingOwner to check: No dose shown on purpose; set one only if the owner wants it.
Do not use, or take care
Hypotension, respiratory depression.
Morphine slows the absorption of oral P2Y12 inhibitors such as ticagrelor and clopidogrel.
Masks ongoing ischemia: pain relief is not reperfusion.
What it does to the ECG and the heart
None directly.
Remember
Analgesia is a comfort measure, not a treatment for the occlusion.
Dissolve the clot when PCI or thrombectomy is too far away
Class: Plasminogen activators
How it works
Convert plasminogen to plasmin, which cuts the fibrin mesh holding a thrombus together and reopens the artery. They cannot tell a coronary clot from one that is sealing a vessel elsewhere, which is why bleeding is the main risk.
A picture of the mechanism appears here with JavaScript on.
When it is used
STEMI within 12 hours of onset when primary PCI cannot be done within 120 minutes of first medical contact: door-to-needle within 30 minutes.
Acute ischemic stroke within 4.5 hours of last known well, with no hemorrhage on imaging.
Cardiac arrest from confirmed (or strongly suspected) pulmonary embolism.
Dose
Use
Dose and route
Repeat and maximum
Source
Adult Stroke: alteplase
0.9 mg/kg (max 90 mg): 10% as a bolus over 1 minute, the rest over 60 minutesIV
—
AHA/ASA acute ischemic stroke guidelines (2019, 2026), as taught in AHA 2020 ACLSOwner to check: Confirm against the 2026 AHA/ASA guideline text.
Adult Stroke: tenecteplase
0.25 mg/kg (max 25 mg) single bolusIV
—
AHA/ASA 2026 acute ischemic stroke guideline (as reported)Owner to check: Confirm against the 2026 AHA/ASA guideline text.
Adult STEMI
Agent-specific weight-based regimensIV
—
ACC/AHA 2025 acute coronary syndromes guidelineOwner to check: Doses vary by agent; none shown on purpose.
Adult Cardiac arrest from pulmonary embolism
Alteplase 50 mg IV bolus (a commonly used regimen); continue CPR for 60–90 minutes after itIV
—
AHA 2020/2025 ACLS: thrombolysis is reasonable for confirmed PE causing arrest and may be considered when PE is suspected; the guidelines name no doseOwner to check: Owner to check: the 50 mg bolus and the 60–90 minute CPR window are common practice, not an AHA-specified regimen.
Do not use, or take care
Any prior intracranial hemorrhage; known cerebral vascular lesion or intracranial tumour.
Active bleeding or bleeding diathesis; suspected aortic dissection.
Significant head trauma or intracranial or spinal surgery recently.
Stroke: blood pressure above 185/110 mm Hg that cannot be lowered before treatment.
After stroke thrombolysis keep BP at or below 180/105 mm Hg for 24 hours.
Watch for angioedema and neurological worsening (bleeding).
What it does to the ECG and the heart
After STEMI lysis: ST resolution of 50% or more and reperfusion arrhythmias (accelerated idioventricular rhythm) suggest the artery has opened.
Time is muscle, and time is brain: the clock starts at symptom onset.
No longer recommended
Practices from older courses that the current guidelines have dropped.
Practice
Why it went
Vasopressin in place of, or with, epinephrine
No survival advantage; removed from the arrest algorithm in 2015.
Atropine for asystole or PEA
No benefit; removed in 2010. Atropine is a bradycardia drug.
Routine calcium in cardiac arrest
No benefit and possible harm; keep it for hyperkalemia, calcium-channel blocker toxicity and hypermagnesemia.
Routine sodium bicarbonate in cardiac arrest
No benefit; keep it for hyperkalemia, sodium-channel blocker toxicity and pre-existing acidosis.
Routine magnesium for VF/pVT
Only for torsades de pointes with a long QT.
High-dose epinephrine
Escalating doses did not improve survival.
Transcutaneous pacing for asystole
Does not improve outcome in cardiac arrest.
Sotalol in the tachycardia algorithm
No longer listed in the 2025 algorithm (procainamide or amiodarone remain).
Guidelines and sources
Reflects the AHA 2020 adult algorithms with the 2023 focused update, updated for the 2025 AHA Guidelines for CPR and ECC where the change could be confirmed; acute coronary syndromes follow the 2025 ACC/AHA guideline and stroke the 2026 AHA/ASA guideline.
Algorithms and doses follow the AHA 2020 Guidelines for CPR and ECC, adult algorithms (Part 3: Adult Basic and Advanced Life Support, Circulation 2020;142(suppl 2):S366–S468), checked for changes in:
2023 AHA Focused Update on Adult Advanced Cardiovascular Life Support (Circulation 2024;149:e254–e273)
2025 AHA Guidelines for CPR and ECC, Part 9: Adult Advanced Life Support
Changes in the 2025 guidelines reflected here:
Synchronized cardioversion of atrial fibrillation: an initial energy of at least 200 J with a biphasic defibrillator is now recommended, rather than a lower first shock.
The tachycardia algorithm refers to the device's recommended energy level rather than listing energies for each rhythm.
Intravenous access is preferred to intraosseous access as the first attempt in cardiac arrest.
Double sequential defibrillation and vector-change defibrillation for refractory VF remain of uncertain benefit.
Sotalol is no longer listed in the tachycardia algorithm; procainamide and amiodarone remain.
Routine calcium and sodium bicarbonate are not recommended in cardiac arrest; both are kept for specific causes.
After ROSC: titrate oxygen to an SpO₂ of 90–98%, keep the MAP at 65 mm Hg or more, and use deliberate temperature control (32–37.5 °C) for patients not following commands.
Polymorphic VT is treated as unstable and defibrillated.
Sources:
Panchal AR, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16 suppl 2):S366–S468.
Perman SM, et al. 2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support. Circulation. 2024;149:e254–e273.
Lavonas EJ, et al. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning. Circulation. 2023;148:e149–e184.
Part 7: Adult Basic Life Support. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
Part 9: Adult Advanced Life Support. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2):S538–S577.
Part 10: Adult and Pediatric Special Circumstances of Resuscitation. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
Part 11: Post–Cardiac Arrest Care. 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2025;152(16 suppl 2).
Rao SV, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025;151(13):e771–e862.
Prabhakaran S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke (AHA/ASA). Stroke. 2026. doi:10.1161/STR.0000000000000513.
The full 2025 guideline text could not be opened when this page was drafted; the 2025 changes listed were confirmed from summaries of AHA's published 2025 algorithms and highlights. Drug doses are the 2020 algorithm doses, which those 2025 algorithms keep. All text and pictures here are original teaching material, not reproductions of AHA algorithms. Education only, not a treatment protocol.